REGEN BIOPHARMA, INC. (RGBPP) Net margin 2017–2025
REGEN BIOPHARMA, INC. (RGBPP) net profit margin by fiscal year — reported net income divided by reported revenue.
-282.5%FY2025 · since FY2017: -7046.0% → -282.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -282.5% | -771.4 pp |
| FY2024 | 488.9% | -544.1 pp |
| FY2023 | 1032.9% | +6422.8 pp |
| FY2022 | -5389.9% | -10969.6 pp |
| FY2021 | 5579.7% | +7964.4 pp |
| FY2020 | -2384.7% | +1901.8 pp |
| FY2019 | -4286.5% | +1552.5 pp |
| FY2018 | -5839.0% | +1207.0 pp |
| FY2017 | -7046.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice